Skip to main content
. 2024 Jan 24;24(3):224–234. doi: 10.2174/0118715206284107231120063630

Table 3.

Inhibition rates measured by the xCELLigence RTCA method after 24 hours of treatment of MCF-7 cells with different combination doses calculated over different percentages of PTX and OLE IC50 doses.

% IC50 Inhibition (%)
10% (OLE 23 µM+PTX 0.75 µM) 65.57 ± 3.19****
20% (OLE 46 µM+PTX 1.5 µM) 49.35 ± 0.96****
30% (OLE 69 µM+PTX 2.25 µM) 46.18 ± 1.85****
40% (OLE 92 µM+PTX 3 µM) 50.72 ± 1.59****
50% (OLE 115 µM+PTX 3.75 µM) 43.56 ± 0.39****
75% (OLE 172.5 µM+PTX 5.63 µM) 49.69 ± 5.28****
100% (OLE 230 µM+PTX 7.5 µM) 42.43 ± 2.17****

Note: ****p < 0.0001 when compared with the control.